Long-term follow-up and analysis for prognostic factors for patients with limited-stage diffuse large-cell lymphoma treated with initial chemotherapy with or without adjuvant radiotherapy.
暂无分享,去创建一个
[1] J. Armitage,et al. Interpretation of clinical trials in diffuse large-cell lymphoma. , 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[2] J. Connors,et al. Brief chemotherapy and involved field radiation therapy for limited-stage, histologically aggressive lymphoma. , 1987, Annals of internal medicine.
[3] R. Fisher,et al. Southwest oncology group clinical trials for intermediate- and high-grade non-Hodgkin's lymphomas. , 1987, Seminars in hematology.
[4] G. Pinkus,et al. The m-BACOD combination chemotherapy regimen in the treatment of diffuse large cell lymphoma. , 1987, Seminars in hematology.
[5] M. Kaminski,et al. Factors predicting survival in adults with stage I and II large-cell lymphoma treated with primary radiation therapy. , 1986, Annals of internal medicine.
[6] T. Miller,et al. Effect of age on therapeutic outcome in advanced diffuse histiocytic lymphoma: the Southwest Oncology Group experience. , 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[7] J. Ultmann,et al. Treatment of diffuse histiocytic lymphoma (DHL) with COMLA (cyclophosphamide, oncovin, methotrexate, leucovorin, cytosine arabinoside): a 10-year experience in a single institution. , 1985, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[8] T. Miller,et al. Chemotherapy with cyclophosphamide, doxorubicin, vincristine, and prednisone alone or with levamisole or with levamisole plus BCG for malignant lymphoma: a Southwest Oncology Group Study. , 1985, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[9] G. Bonadonna,et al. CVP versus BACOP Chemotherapy Sequentially Combined with Irradiation in Stage I–II Diffuse Non-Hodgkin’s Lymphomas , 1985 .
[10] N. Nissen,et al. A randomized study of radiotherapy versus radiotherapy plus chemotherapy in stage I‐II non‐hodgkin's lymphomas , 2006, Cancer.
[11] T. Miller,et al. Initial chemotherapy for clinically localized lymphomas of unfavorable histology. , 1983, Blood.
[12] R. Hartsock,et al. Improved complete remission rates and survival for patients with large cell lymphoma treated with chemoimmunotherapy: A southwest oncology group study , 1983, Cancer.
[13] C. Bloomfield,et al. Curative radiotherapy for localized diffuse histiocytic lymphoma. , 1980, Cancer treatment reports.
[14] T. Landberg,et al. CVP—Remission—maintenance in stage I or II non‐Hodgkin's lymphomas Preliminary results of a randomized study , 1979, Cancer.
[15] L. Prosnitz,et al. Results of radiotherapy in control of stage I and II non‐Hodgkin's lymphoma , 1979, Cancer.
[16] Stephen E. Jones,et al. CHEMOTHERAPY OF LOCALISED HISTIOCYTIC LYMPHOMA , 1979, The Lancet.
[17] R. Fisher,et al. Prognostic factors for advanced diffuse histiocytic lymphoma following treatment with combination chemotherapy. , 1977, The American journal of medicine.
[18] V. Devita,et al. ADVANCED DIFFUSE HISTIOCYTIC LYMPHOMA, A POTENTIALLY CURABLE DISEASE RESULTS WITH COMBINATION CHEMOTHERAPY , 1975, The Lancet.
[19] Z. Fuks,et al. Non‐Hodgkin's lymphomas. V. Results of radiotherapy , 1973, Cancer.